BUILD A HEART SAVE A LIFE
IMPORTANT Investor Update – 12/8/18
|
Effective January 31st, 2019 we will no longer be accepting investments through our equity crowdfunding offering. |
By Emilia Benton, Correspondent Updated 10:11 am CDT, Tuesday, October 23, 2018 According to U.S. Government Information on Organ Donation and Transplantation, hundreds of thousands of patients across the U.S. are currently on a waiting list for a transplanted organ, and 20 people die each day waiting for a transplant. However, researchers within the Texas Medical Center…
Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…
In February of this year, we announced our Regulation A+ crowdfunding campaign to give everyone the opportunity to invest in BIOLIFE4D and share our mission to change the way heart disease is treated forever. We’ve received a tremendous amount of support throughout the year from our investors and are thankful to be working with each…
